These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 28740230)

  • 1. NMR analysis reveals significant differences in the plasma metabolic profiles of Niemann Pick C1 patients, heterozygous carriers, and healthy controls.
    Probert F; Ruiz-Rodado V; Vruchte DT; Nicoli ER; Claridge TDW; Wassif CA; Farhat N; Porter FD; Platt FM; Grootveld M
    Sci Rep; 2017 Jul; 7(1):6320. PubMed ID: 28740230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary excretion and metabolism of miglustat and valproate in patients with Niemann-Pick type C1 disease: One- and two-dimensional solution-state (1)H NMR studies.
    Probert F; Ruiz-Rodado V; Zhang X; te Vruchte D; Claridge TD; Edgar M; Tocchio AZ; Lachmann RH; Platt FM; Grootveld M
    J Pharm Biomed Anal; 2016 Jan; 117():276-88. PubMed ID: 26397207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human and mouse neuroinflammation markers in Niemann-Pick disease, type C1.
    Cologna SM; Cluzeau CV; Yanjanin NM; Blank PS; Dail MK; Siebel S; Toth CL; Wassif CA; Lieberman AP; Porter FD
    J Inherit Metab Dis; 2014 Jan; 37(1):83-92. PubMed ID: 23653225
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Ruiz-Rodado V; Nicoli ER; Probert F; Smith DA; Morris L; Wassif CA; Platt FM; Grootveld M
    J Proteome Res; 2016 Oct; 15(10):3511-3527. PubMed ID: 27503774
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered transition metal homeostasis in Niemann-Pick disease, type C1.
    Hung YH; Faux NG; Killilea DW; Yanjanin N; Firnkes S; Volitakis I; Ganio G; Walterfang M; Hastings C; Porter FD; Ory DS; Bush AI
    Metallomics; 2014 Mar; 6(3):542-53. PubMed ID: 24343124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect.
    Nadjar Y; Hütter-Moncada AL; Latour P; Ayrignac X; Kaphan E; Tranchant C; Cintas P; Degardin A; Goizet C; Laurencin C; Martzolff L; Tilikete C; Anheim M; Audoin B; Deramecourt V; De Gaillarbois TD; Roze E; Lamari F; Vanier MT; Héron B
    Orphanet J Rare Dis; 2018 Oct; 13(1):175. PubMed ID: 30285904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Miglustat With Swallowing Outcomes in Niemann-Pick Disease, Type C1.
    Solomon BI; Smith AC; Sinaii N; Farhat N; King MC; Machielse L; Porter FD
    JAMA Neurol; 2020 Dec; 77(12):1564-1568. PubMed ID: 32897301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling.
    Fan M; Sidhu R; Fujiwara H; Tortelli B; Zhang J; Davidson C; Walkley SU; Bagel JH; Vite C; Yanjanin NM; Porter FD; Schaffer JE; Ory DS
    J Lipid Res; 2013 Oct; 54(10):2800-14. PubMed ID: 23881911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of miglustat on evolution of atypical presentation of late-infantile-onset Niemann-Pick disease type C with early cognitive impairment, behavioral dysfunction, epilepsy, ophthalmoplegia, and cerebellar involvement: a case report.
    Cuisset JM; Sukno S; Trauffler A; Latour P; Dobbelaere D; Michaud L; Vallée L
    J Med Case Rep; 2016 Sep; 10(1):241. PubMed ID: 27599728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced cerebellar neurodegeneration after combined therapy with cyclodextrin/allopregnanolone and miglustat in NPC1: a mouse model of Niemann-Pick type C1 disease.
    Maass F; Petersen J; Hovakimyan M; Schmitt O; Witt M; Hawlitschka A; Lukas J; Rolfs A; Wree A
    J Neurosci Res; 2015 Mar; 93(3):433-42. PubMed ID: 25400034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The National Niemann-Pick Type C1 Disease Database: correlation of lipid profiles, mutations, and biochemical phenotypes.
    Garver WS; Jelinek D; Meaney FJ; Flynn J; Pettit KM; Shepherd G; Heidenreich RA; Vockley CM; Castro G; Francis GA
    J Lipid Res; 2010 Feb; 51(2):406-15. PubMed ID: 19744920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of structural neuroimaging biomarkers in a series of adult patients with Niemann-Pick type C under treatment.
    Masingue M; Adanyeguh I; Nadjar Y; Sedel F; Galanaud D; Mochel F
    Orphanet J Rare Dis; 2017 Feb; 12(1):22. PubMed ID: 28148276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retinal axonal degeneration in Niemann-Pick type C disease.
    Havla J; Moser M; Sztatecsny C; Lotz-Havla AS; Maier EM; Hizli B; Schinner R; Kümpfel T; Strupp M; Bremova-Ertl T; Schneider SA
    J Neurol; 2020 Jul; 267(7):2070-2082. PubMed ID: 32222928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved neuroprotection using miglustat, curcumin and ibuprofen as a triple combination therapy in Niemann-Pick disease type C1 mice.
    Williams IM; Wallom KL; Smith DA; Al Eisa N; Smith C; Platt FM
    Neurobiol Dis; 2014 Jul; 67():9-17. PubMed ID: 24631719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Two Liver Treatment Strategies in a Mouse Model of Niemann-Pick-Disease Type C1.
    Ebner L; Gläser A; Bräuer A; Witt M; Wree A; Rolfs A; Frank M; Vollmar B; Kuhla A
    Int J Mol Sci; 2018 Mar; 19(4):. PubMed ID: 29587349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacologic Treatment Assigned for Niemann Pick Type C1 Disease Partly Changes Behavioral Traits in Wild-Type Mice.
    Schlegel V; Thieme M; Holzmann C; Witt M; Grittner U; Rolfs A; Wree A
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress in Niemann-Pick type C patients: a protective role of N-butyl-deoxynojirimycin therapy.
    Ribas GS; Pires R; Coelho JC; Rodrigues D; Mescka CP; Vanzin CS; Biancini GB; Negretto G; Wayhs CA; Wajner M; Vargas CR
    Int J Dev Neurosci; 2012 Oct; 30(6):439-44. PubMed ID: 22820346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnosis of niemann-pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots.
    Jiang X; Sidhu R; Orsini JJ; Farhat NY; Porter FD; Berry-Kravis E; Schaffer JE; Ory DS
    Mol Genet Metab; 2019 Feb; 126(2):183-187. PubMed ID: 30172462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated cerebrospinal fluid ubiquitin C-terminal hydrolase-L1 levels correlate with phenotypic severity and therapeutic response in Niemann-Pick disease, type C1.
    Cawley NX; Giddens S; Farhat NM; Luke RA; Scott KEJ; Mohamed HO; Dang Do A; Berry-Kravis E; Cologna SM; Liu F; Porter FD
    Mol Genet Metab; 2023 Nov; 140(3):107656. PubMed ID: 37517328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estimating the prevalence of Niemann-Pick disease type C (NPC) in the United States.
    Burton BK; Ellis AG; Orr B; Chatlani S; Yoon K; Shoaff JR; Gallo D
    Mol Genet Metab; 2021; 134(1-2):182-187. PubMed ID: 34304992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.